Taghizadeh-Kermani A[au] - Search Results

Year	Number of Results
2006	1
2008	1
2011	1
2013	2
2014	3
2015	1
2016	1
2018	2
2019	2
2021	1
2022	2
2023	3
2024	3
2025	0

1

A nested variant of urothelial carcinoma of the urethra and urinary bladder: A case report and review of literature.

Taghizadeh Kermani A, Kalantari MR, Pishevar Feizabad Z, Arastouei S. Taghizadeh Kermani A, et al. Clin Case Rep. 2023 May 25;11(6):e7360. doi: 10.1002/ccr3.7360. eCollection 2023 Jun. Clin Case Rep. 2023. PMID: 37251747 Free PMC article.

2

Leiomyosarcoma, a rare smooth muscle cancer in the pancreas: An adjuvant radiotherapy treatment approach.

Taghizadeh Kermani A, Khooei A, Aliakbarian M, Arastouei S. Taghizadeh Kermani A, et al. Cancer Rep (Hoboken). 2023 Jun;6(6):e1820. doi: 10.1002/cnr2.1820. Epub 2023 Apr 24. Cancer Rep (Hoboken). 2023. PMID: 37095058 Free PMC article.

3

Accuracy of sentinel node biopsy in the staging of non-small cell lung carcinomas: systematic review and meta-analysis of the literature.

Taghizadeh Kermani A, Bagheri R, Tehranian S, Shojaee P, Sadeghi R, N Krag D. Taghizadeh Kermani A, et al. Lung Cancer. 2013 Apr;80(1):5-14. doi: 10.1016/j.lungcan.2013.01.001. Epub 2013 Jan 23. Lung Cancer. 2013. PMID: 23352034 Review.

4

Economical Evaluation of Prostate Cancer Treatment Using Intensity-Modulated Radiation Therapy, 3-Dimensional Conformal Radiation Therapy and Radical Prostatectomy: A Systematic Review.

Adel A, Rezapour A, Aboutorabi A, Taghizadeh Kermani A, Ghorbani H. Adel A, et al. Among authors: taghizadeh kermani a. Value Health Reg Issues. 2024 Jan;39:57-65. doi: 10.1016/j.vhri.2023.08.009. Epub 2023 Nov 17. Value Health Reg Issues. 2024. PMID: 37979544 Free article.

5

A randomized clinical trial on the antitumoral effects of low molecular weight heparin in the treatment of esophageal cancer.

Taghizadeh Kermani A, Hosseini S, Fanipakdel A, Joudi Mashhad M, Akhavan Rezayat K, Zardadi M, Gholami A, Javadinia SA, Ferns GA, Avan A. Taghizadeh Kermani A, et al. J Cell Physiol. 2019 Apr;234(4):4191-4199. doi: 10.1002/jcp.27177. Epub 2018 Oct 26. J Cell Physiol. 2019. PMID: 30362518 Clinical Trial.

6

Prognostic significance of adjuvant radiation therapy in adenocarcinoma of the cecum.

Hosseini S, Bananzadeh AM, Mohammadianpanah M, Salek R, Taghizadeh-Kermani A. Hosseini S, et al. Among authors: taghizadeh kermani a. Radiat Oncol J. 2018 Mar;36(1):45-53. doi: 10.3857/roj.2017.00332. Epub 2018 Mar 5. Radiat Oncol J. 2018. PMID: 29506326 Free PMC article.

7

Predictive Value of Endoscopic Observations and Biopsy After Neoadjuvant Chemoradiotherapy in Assessing the Pathologic Complete Response of Patients With Esophageal Squamous Cell Carcinoma.

Taghizadeh Kermani A, Ghanbarzadeh R, Joudi Mashhad M, Javadinia SA, Emadi Torghabeh A. Taghizadeh Kermani A, et al. Front Oncol. 2022 May 11;12:859079. doi: 10.3389/fonc.2022.859079. eCollection 2022. Front Oncol. 2022. PMID: 35646696 Free PMC article.

8

Changes in daily activities of cancer patients after diagnosis: how do canadian and Iranian patients perceive the change?

Shahidi J, Taghizadeh-Kermani A, Gohari MR, Ghavamnasiri MR, Khoshroo F, Pourali L, Cohen SR. Shahidi J, et al. Among authors: taghizadeh kermani a. Iran J Cancer Prev. 2014 Winter;7(1):28-34. Iran J Cancer Prev. 2014. PMID: 25250145 Free PMC article.

9

Effects of a polyherbal formulation on the quality of life and survival of patients with common upper gastrointestinal cancers: A randomized placebo-controlled trial.

Fani Pakdel A, Hatami A, Salek R, Taghizadeh-Kermani A, Javadinia SA, Ghorbani A. Fani Pakdel A, et al. Among authors: taghizadeh kermani a. Avicenna J Phytomed. 2021 Nov-Dec;11(6):566-575. doi: 10.22038/AJP.2021.18132. Avicenna J Phytomed. 2021. PMID: 34804894 Free PMC article.

10

Safety evaluation of the trastuzumab biosimilar in Iranian women with HER2-positive breast cancer undergoing adjuvant chemotherapy: a post-marketing surveillance.

Zahedi F, Jafari A, Nasiri Motlagh B, Hamedi SH, Salek R, Khandoozi S, Farshchian N, Shahidsales S, Mafi AR, Hosseini S, Amouheidari A, Varshoee Tabrizi F, Khanjani N, Ahmadloo N, Dayyani M, Khodabakhshi R, Mojahed MM, Keshvari M, Fazl Ersi M, Mirsadraee M, Izadpanahi P, Saadipoor A, Nasrollahi H, Anbiaee R, Emadi Torghabeh A, Keramati A, Amiran SA, Bayat Mokhtari N, Taghizadeh Kermani A, Anvari K, Sadeghi Ivari M, Dayani M, Amirabadi A, Saeidi Saedi H, Sabzvari A, Kafi H, Homaei Shandiz F. Zahedi F, et al. Among authors: taghizadeh kermani a. Expert Opin Drug Saf. 2024 Aug 1:1-6. doi: 10.1080/14740338.2024.2385483. Online ahead of print. Expert Opin Drug Saf. 2024. PMID: 39076099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year